Citation: | WANG Rongrong, SUN Wenjun, LIU Jiangwei, ZHENG Aiping, ZHANG Hui, LYU Lixun. Preparation of curcumin nanocrystalline injection and evaluation of its in vivo and in vitro properties[J]. Journal of China Pharmaceutical University, 2022, 53(1): 54-59. DOI: 10.11665/j.issn.1000-5048.20220108 |
[1] |
. J Intensive Care,2018,6:30.
|
[2] |
Rong P,Meng JZ,Chen Y. Advance in pathogenesis and strategies of protective and therapeutic in heat stroke[J]. J Biomed Eng Res(生物医学工程研究),2010,29(4):287-292.
|
[3] |
Priyadarsini KI. The chemistry of curcumin:from extraction to therapeutic agent[J]. Molecules,2014,19(12):20091-20112.
|
[4] |
Odot J,Albert P,Carlier A,et al. In vitro and in vivo anti-tumoral effect of curcumin against melanoma cells[J]. Int J Cancer,2004,111(3):381-387.
|
[5] |
Ma N,Li JJ,Song LY,et al. Effects of curcumin pretreatment on the oxidative stress and apoptosis of cardiomyocytes in heatstroke rats in a dry heat environment[J]. Chin J Comp Med(中国比较医学杂志),2018,28(12):14-18.
|
[6] |
Xia L,Dong X,Kang Y,et al. Protective effects of curcumin on intestinal mucosa injury of heatstroke rats in the dry heat envrionment of desert and its effects on TLR4/NF-κB signaling pathway[J]. Prog Mod Biomed(现代生物医学进展),2017,17(34):6648-6652.
|
[7] |
Ubeyitogullari A,Ciftci ON. A novel and green nanoparticle formation approach to forming low-crystallinity curcumin nanoparticles to improve curcumin''s bioaccessibility[J]. Sci Rep,2019,9(1):19112.
|
[8] |
Wang LL,Du J,Zhou YQ,et al. Safety of nanosuspensions in drug delivery[J]. Nanomed-Nanotechnol Biol Med,2017,13(2):455-469.
|
[9] |
Bala I,Bhardwaj V,Hariharan S,et al. Sustained release nanoparticulate formulation containing antioxidant-ellagic acid as potential prophylaxis system for oral administration[J]. J Drug Target,2006,14(1):27-34.
|
[10] |
Medarevi? D,Djuri? J,Ibri? S,et al. Optimization of formulation and process parameters for the production of carvedilol nanosuspension by wet media milling[J]. Int J Pharm,2018,540(1/2):150-161.
|
[11] |
Rabinow BE. Nanosuspensions in drug delivery[J]. Nat Rev Drug Discov,2004,3(9):785-796.
|
[12] |
Liu T,Müller RH,M?schwitzer JP. Effect of drug physico-chemical properties on the efficiency of top-down process and characterization of nanosuspension[J]. Expert Opin Drug Deliv,2015,12(11):1741-1754.
|
[13] |
Andersson SBE,Alvebratt C,Bergstr?m CAS. Controlled suspensions enable rapid determinations of intrinsic dissolution rate and apparent solubility of poorly water-soluble compounds[J]. Pharm Res,2017,34(9):1805-1816.
|
[14] |
Zhang SW,Li XZ,Li WS,et al. Preparation and characterization of curcumin nanosuspensions[J]. Chem Ind For Prod(林产化学与工业),2016,36(2):109-114.
|
[15] |
Gigliobianco MR,Casadidio C,Censi R,et al. Nanocrystals of poorly soluble drugs:drug bioavailability and physicochemical stability[J]. Pharmaceutics,2018,10(3):134.
|
[16] |
Liu P,Rong XY,Laru J,et al. Nanosuspensions of poorly soluble drugs:preparation and development by wet milling[J]. Int J Pharm,2011,411(1/2):215-222.
|
[1] | KANG Zhenhua, CHEN Yuandong, XU Cheng, YOU Jian, QIN Minjian, QIN Yong. Optimization of pramipexole hydrochloride sustained-release tablets using Box-Behnken design and mechanism of in vitro drug release[J]. Journal of China Pharmaceutical University, 2015, 46(1): 66-72. DOI: 10.11665/j.issn.1000-5048.20150108 |
[2] | SONG Xiao-chen, CHEN Lin-lin, QI Jin, YU Bo-yang, ZHU Dan-ni. Pharmacokinetics of hapagoside and its metabolite in rats[J]. Journal of China Pharmaceutical University, 2011, 42(3): 262-265. |
[3] | Pharmacokinetics and Bioavailability of Cinnamic Acid in Mice[J]. Journal of China Pharmaceutical University, 2004, (4): 38-40. |
[4] | Pharmacokinetics of 0325k1-1 in Dogs[J]. Journal of China Pharmaceutical University, 2003, (4): 79-81. |
[5] | Determination of Olanzapine in Plasma by HPLC and Its Pharmacokinetics in Men[J]. Journal of China Pharmaceutical University, 2002, (5): 44-47. |
[6] | Determination ofRepaglinide in Plasma by HPLC and Its Pharmacokinetics in Men[J]. Journal of China Pharmaceutical University, 2001, (1): 32-35. |
[7] | Pharmacokinetics of Aceclofenac in Rats[J]. Journal of China Pharmaceutical University, 1998, (4): 68-70. |
[8] | Gas Chromatographic Determination of Aloperine and Its Pharmacokinetics[J]. Journal of China Pharmaceutical University, 1990, (6): 361-363. |
[9] | PHARMACOKINETICS OF MATRINR IN RABBITS[J]. Journal of China Pharmaceutical University, 1986, (4): 309-311. |
[10] | PHARMACOKINETICS OF OCTANOYLPRIMAQUINE IN RABBITS[J]. Journal of China Pharmaceutical University, 1986, (2): 125-128. |
1. |
吕春艳,厚晓庆,崔闻宇,张文君,王文倩,韩锐. 基于多效应稳定剂改善药物纳米结晶稳定性研究进展. 中国药学杂志. 2024(16): 1488-1494 .
![]() |